One possible explanation is that IgG4 produced in tumor microenvironment and stroma may be associated with chronic antigen challenge associated with Th2 cytokines including IL-4, IL-10, and IL-13, which causes inappropriate host immune tolerance against malignancies and tumor progression [28]. This evidence concerns the gene IL10 and neoplasm.